The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma

Respiratory Medicine

Volumn 97, Issue 3, 2003, Pages 234-241

  Ringdal, N ^a   Eliraz, A ^b   Pruzinec, P ^c   Weber, H H ^d   Mulder, P G H ^e   Akveld, Martijn ^f   Bateman, E D ^g   Funder Jorgensen, N ^h   Pedersen, C ^h   Theman, K ^h   Ziegler, J ^h   Erkan, F ^h   Misirligil, Z ^h   Sayiner, A ^h   Yildirim, N ^h   Yashina, L ^h   Feschenko, Y ^h   Aitchison, W ^h   Bremner, A ^h   Calder, B ^h   Canning, G ^h   Cooper, A ^h   Darrah, A ^h   Dobson, P ^h   Doyle, M ^h   Ferry, D ^h   Gunn, S ^h   Hackett, G ^h   Ham, J ^h   Lee, P ^h   Lenton, C ^h   Litchfield, J ^h   Lloyd, R ^h   Marshall, A ^h   McGoldrick, H ^h   Penney, B ^h   Shearer, P ^h   Sheldon, D ^h   Singh, G ^h   more..

^a Kaplan Medical Centre ^*  (Norway)

^b KAPLAN MEDICAL CENTER   (Israel)

^c UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^d GlaxoSmithKline R and D ^*  (Germany)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f GLAXOSMITHKLINE   (Ireland)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

^h NONE

Author keywords

Asthma; Combination drug; Fluticasone propionate; Montelukast; Salmeterol; Therapy

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BRONCHITIS; CANDIDIASIS; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INFLUENZA; LUNG FUNCTION; MALE; MEDICAL RECORD; MULTICENTER STUDY; OROPHARYNX; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SORE THROAT; SYMPTOMATOLOGY; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

EID: 0037372118     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2003.1436     Document Type: Article

References (25)

1. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma: United States 1960-1995. MMWR 1998; 47: 1-28.
2. Anderson HR, Butland BK, Strachan DP. Trends in prevalence and severity of childhood asthma. BMJ 1994; 308: 1600-1604.
3. Robertson CF, Rubinfield AR, Bowes G. Pediatric asthma deaths in Victoria. The mild are at risk. Pediatr Pulmonol 1992; 13: 95-100.
4. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2. National Institutes of Health, National Heart, Lung and Blood Institute. July 1997, NIH Publication Number 97-4051.
5. British Thoracic Society. The British guidelines on asthma management. 1995 review and position statement. Thorax 1997; 52 (Suppl. I): S1-S21.
6. Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 1998; 102: 531-538.
7. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group. Lancet 1994; 344: 219-224.
8. Woolcock AJ, Lundbäck B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroid with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481-1488.
9. Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group. Ann Allergy Asthma Immunol 1999; 82: 383-389.
10. Van Noord JA, Schreurs AJ, Mol SJ, Mulder PG. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma. Thorax 1999; 54: 207-212.
11. Johnson M. Combination therapy for asthma: complementary effects of long-acting beta-agonists and corticosteroids. Curr Allergy Clin Immunol 2002; 15: 16-22.
12. Merck Sharp & Dohme Ltd. Summary of product characteristics. 27 June 2000. Available from URL: http://srs.vhn.net/eMc/documents/ 01100/01192/SPC.1192.html.
13. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. National Institutes of Health, National Heart, Lung and Blood Institute. 2002, Updated from: NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention Issued January, 1995. NIH Publication No. 02-3659.
14. Dempsey OJ. Leukotriene receptor antagonist therapy. Postgrad Med J 2000; 76: 767-773.
15. Laviolette M, Malmström K, Lu S, et al for the Montelukast/Beclomethasone Additivity Group. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 1999; 160: 1862-1868.
16. Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 2000; 106: 1088-1095.
17. Liang KY, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
18. Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy Trial). Respir Med 2000; 94: 612-621.
19. Santenello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 1999; 14: 23-27.
20. O'Connor RD, O'Donnell JC, Pinto LA, Wiener DJ, Legorreta AP. Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma. Chest 1999; 121: 1028-1035.
21. Stempel DA, O'Donnell JC, Meyer JW. Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs. J Allergy Clin Immunol 2002; 109: 433-439.
22. Kelloway JS, Wyatt RA, Adlis SK. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154: 1349-1352.
23. Robinson DS, Campbell D, Barnes PJ. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomized double-blind placebo-controlled trial. Lancet 2001; 357: 2007-2011.
24. Fish JE, Israel E, Murray JJ, Emmett A, Boone R, Yancey SW, Rickard KA. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. Chest 2001; 120: 423-430.
25. Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. J Allergy Clin Immunol 1999; 103: 1075-1080.